|
2026-10-02 |
2026-10-01 |
S
Sale
|
Chief Executive Officer
Executive Director
|
86,149
+40.6%
29.44
US$2,666,223
|
86,149
+40.6%
|
29.44
|
US$2,666,223
|
|
|
2026-10-01 |
2026-10-01 |
PrS
Proposed sale
|
Officer
Officer
|
66,687
67.82
US$61,475
|
66,687
|
67.82
|
US$61,475
|
|
|
2026-09-24 |
2026-09-24 |
PrS
Proposed sale
|
Former Officer
Officer
|
34,278
400.43
US$952,635
|
34,278
|
400.43
|
US$952,635
|
|
|
2026-09-18 |
2026-09-17 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
1,000
-0.1%
4.56
US$100,000
|
1,000
-0.1%
|
4.56
|
US$100,000
|
|
|
2026-09-17 |
2026-09-17 |
PrS
Proposed sale
|
Officer
Officer
|
1,000
4.56
US$100,000
|
1,000
|
4.56
|
US$100,000
|
|
|
2026-09-17 |
2026-09-16 |
S
Sale
|
VP OF FINANCE AND CONTROLLER
Officer
|
1,000
-1.1%
4.64
US$100,000
|
1,000
-1.1%
|
4.64
|
US$100,000
|
|
|
2026-09-16 |
2026-09-16 |
PrS
Proposed sale
|
Officer
Officer
|
1,000
4.64
US$100,000
|
1,000
|
4.64
|
US$100,000
|
|
|
2026-09-16 |
2026-09-15 |
PlS
Planned sale
|
CEO, Counterpart Health
Officer
|
1,000
-20.4%
4.72
US$100,000
|
1,000
-20.4%
|
4.72
|
US$100,000
|
|
|
2026-09-15 |
2026-09-15 |
S
Sale
|
Chief Legal Officer
Officer
|
1,000
-0.4%
4.78
US$100,000
|
1,000
-0.4%
|
4.78
|
US$100,000
|
|
|
2026-09-15 |
2026-09-15 |
S
Sale
|
CEO, Medicare Advantage
Officer
|
1,000
-0.3%
4.78
US$100,000
|
1,000
-0.3%
|
4.78
|
US$100,000
|
|
|
2026-09-15 |
2026-09-15 |
PrS
Proposed sale
|
Officer
Officer
|
1,000
4.66
US$100,000
|
1,000
|
4.66
|
US$100,000
|
|
|
2026-09-15 |
2026-09-15 |
PrS
Proposed sale
|
Officer
Officer
|
1,000
4.66
US$100,000
|
1,000
|
4.66
|
US$100,000
|
|
|
2026-09-15 |
2026-09-15 |
PrS
Proposed sale
|
Former Officer
Officer
|
1,000
4.64
US$100,000
|
1,000
|
4.64
|
US$100,000
|
|
|
2026-09-15 |
2026-09-15 |
PrS
Proposed sale
|
Officer
Officer
|
1,000
4.72
US$100,000
|
1,000
|
4.72
|
US$100,000
|
|
|
2026-09-14 |
2026-09-14 |
S
Sale
|
VP OF FINANCE AND CONTROLLER
Officer
|
1,000
-6.7%
5.16
US$100,000
|
1,000
-6.7%
|
5.16
|
US$100,000
|
|
|
2026-09-14 |
2026-09-14 |
PrS
Proposed sale
|
Officer
Officer
|
1,000
5.16
US$100,000
|
1,000
|
5.16
|
US$100,000
|
|
|
2026-08-31 |
2026-08-31 |
PrS
Proposed sale
|
Officer
Officer
|
73,516
4.15
US$305,113
|
73,516
|
4.15
|
US$305,113
|
|
|
2026-08-17 |
2026-08-17 |
S
Sale
|
Interim CFO
Officer
|
17,775
-1.4%
4.39
US$78,032
|
17,775
-1.4%
|
4.39
|
US$78,032
|
|
|
2026-08-17 |
2026-08-17 |
PrS
Proposed sale
|
Officer
Officer
|
16,942
4.27
US$72,342
|
16,942
|
4.27
|
US$72,342
|
|
|
2026-08-14 |
2026-08-14 |
PrS
Proposed sale
|
Officer
Officer
|
474,801
4.57
US$2,171,597
|
474,801
|
4.57
|
US$2,171,597
|
|
|
2026-08-10 |
2026-08-10 |
S
Sale
|
Chief Executive Officer
Executive Director
|
87,798
-0.9%
4.65
US$408,261
|
87,798
-0.9%
|
4.65
|
US$408,261
|
|
|
2026-08-10 |
2026-08-10 |
PrS
Proposed sale
|
Officer
Officer
|
85,704
4.57
US$391,667
|
85,704
|
4.57
|
US$391,667
|
|
|
2026-08-07 |
2026-08-07 |
PrS
Proposed sale
|
Officer
Officer
|
441,601
4.85
US$2,141,989
|
441,601
|
4.85
|
US$2,141,989
|
|
|
2026-07-20 |
2026-07-20 |
PlS
Planned sale
|
Chief Legal Officer
Officer
|
51,700
-3.3%
4.51
US$233,167
|
51,700
-3.3%
|
4.51
|
US$233,167
|
|
|
2026-07-20 |
2026-07-20 |
PrS
Proposed sale
|
Officer
Officer
|
51,700
4.62
US$238,854
|
51,700
|
4.62
|
US$238,854
|
|
|
2026-07-17 |
2026-07-17 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
4,839
-0.2%
4.53
US$21,921
|
4,839
-0.2%
|
4.53
|
US$21,921
|
|
|
2026-07-17 |
2026-07-17 |
PrS
Proposed sale
|
Officer
Officer
|
4,839
4.40
US$21,292
|
4,839
|
4.40
|
US$21,292
|
|
|
2026-07-16 |
2026-07-15 |
S
Sale
|
Chief Executive Officer
Executive Director
|
62,711
-0.7%
4.67
US$292,860
|
62,711
-0.7%
|
4.67
|
US$292,860
|
|
|
2026-07-16 |
2026-07-15 |
S
Sale
|
CEO, Counterpart Health
Officer
|
24,215
-2.1%
4.67
US$113,084
|
24,215
-2.1%
|
4.67
|
US$113,084
|
|
|
2026-07-16 |
2026-07-15 |
S
Sale
|
CEO, Medicare Advantage
Officer
|
13,119
-0.5%
4.67
US$61,266
|
13,119
-0.5%
|
4.67
|
US$61,266
|
|
|
2026-07-16 |
2026-07-15 |
S
Sale
|
Chief Legal Officer
Officer
|
10,519
-0.7%
4.67
US$49,124
|
10,519
-0.7%
|
4.67
|
US$49,124
|
|
|
2026-07-16 |
2026-07-15 |
S
Sale
|
Interim CFO
Officer
|
4,630
-0.4%
4.67
US$21,622
|
4,630
-0.4%
|
4.67
|
US$21,622
|
|
|
2026-07-15 |
2026-07-15 |
PrS
Proposed sale
|
Officer
Officer
|
4,486
4.68
US$20,994
|
4,486
|
4.68
|
US$20,994
|
|
|
2026-07-15 |
2026-07-15 |
PrS
Proposed sale
|
Officer
Officer
|
10,192
4.68
US$47,699
|
10,192
|
4.68
|
US$47,699
|
|
|
2026-07-15 |
2026-07-15 |
PrS
Proposed sale
|
Officer
Officer
|
12,712
4.68
US$59,492
|
12,712
|
4.68
|
US$59,492
|
|
|
2026-07-15 |
2026-07-15 |
PrS
Proposed sale
|
Officer
Officer
|
60,765
4.68
US$284,380
|
60,765
|
4.68
|
US$284,380
|
|
|
2026-07-15 |
2026-07-15 |
PrS
Proposed sale
|
Officer
Officer
|
23,463
4.68
US$109,807
|
23,463
|
4.68
|
US$109,807
|
|
|
2026-07-09 |
2026-07-08 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
2,384
-0.1%
4.68
US$11,157
|
2,384
-0.1%
|
4.68
|
US$11,157
|
|
|
2026-07-08 |
2026-07-08 |
PrS
Proposed sale
|
Officer
Officer
|
2,384
5.00
US$11,920
|
2,384
|
5.00
|
US$11,920
|
|
|
2026-07-06 |
2026-07-06 |
S
Sale
|
CEO, Medicare Advantage
Officer
|
6,229
-0.2%
5.26
US$32,765
|
6,229
-0.2%
|
5.26
|
US$32,765
|
|
|
2026-07-06 |
2026-07-06 |
PrS
Proposed sale
|
Officer
Officer
|
6,229
5.26
US$32,765
|
6,229
|
5.26
|
US$32,765
|
|
|
2026-07-01 |
2026-07-01 |
S
Sale
|
Chief Executive Officer
Executive Director
|
313,476
-3.2%
5.32
US$1,667,692
|
313,476
-3.2%
|
5.32
|
US$1,667,692
|
|
|
2026-07-01 |
2026-07-01 |
PrS
Proposed sale
|
Officer
Officer
|
309,558
5.39
US$1,668,518
|
309,558
|
5.39
|
US$1,668,518
|
|
|
2026-06-18 |
2026-06-17 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
2,360
-0.1%
4.78
US$11,281
|
2,360
-0.1%
|
4.78
|
US$11,281
|
|
|
2026-06-17 |
2026-06-17 |
PrS
Proposed sale
|
Officer
Officer
|
2,360
4.94
US$11,658
|
2,360
|
4.94
|
US$11,658
|
|
|
2026-06-17 |
2026-06-16 |
S
Sale
|
VP OF FINANCE AND CONTROLLER
Officer
|
12,102
-3.9%
4.86
US$58,816
|
12,102
-3.9%
|
4.86
|
US$58,816
|
|
|
2026-06-16 |
2026-06-16 |
PrS
Proposed sale
|
Officer
Officer
|
14,155
4.94
US$69,926
|
14,155
|
4.94
|
US$69,926
|
|
|
2026-06-16 |
2026-06-15 |
S
Sale
|
Chief Legal Officer
Officer
|
4,681
-0.3%
4.61
US$21,579
|
4,681
-0.3%
|
4.61
|
US$21,579
|
|
|
2026-06-16 |
2026-06-15 |
S
Sale
|
CEO, Medicare Advantage
Officer
|
6,350
-0.2%
4.61
US$29,274
|
6,350
-0.2%
|
4.61
|
US$29,274
|
|
|
2026-06-15 |
2026-06-15 |
PrS
Proposed sale
|
Officer
Officer
|
5,342
4.81
US$25,695
|
5,342
|
4.81
|
US$25,695
|
|
|
2026-06-15 |
2026-06-15 |
PrS
Proposed sale
|
Officer
Officer
|
7,556
4.81
US$36,344
|
7,556
|
4.81
|
US$36,344
|
|
|
2026-06-11 |
2026-06-11 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
7,289
-0.3%
4.91
US$35,789
|
7,289
-0.3%
|
4.91
|
US$35,789
|
|
|
2026-06-11 |
2026-06-11 |
PrS
Proposed sale
|
Officer
Officer
|
7,289
4.89
US$35,643
|
7,289
|
4.89
|
US$35,643
|
|
|
2026-06-11 |
2026-06-11 |
PrS
Proposed sale
|
Officer
Officer
|
7,289
4.89
US$35,643
|
7,289
|
4.89
|
US$35,643
|
|
|
2026-05-28 |
2026-05-28 |
PlS
Planned sale
|
CEO, Counterpart Health
Officer
|
220,426
-13.7%
3.99
US$879,500
|
220,426
-13.7%
|
3.99
|
US$879,500
|
|
|
2026-05-28 |
2026-05-28 |
PrS
Proposed sale
|
Officer
Officer
|
220,426
3.99
US$880,577
|
220,426
|
3.99
|
US$880,577
|
|
|
2026-05-19 |
2026-05-18 |
S
Sale
|
Non-Executive Director
|
67,160
-19.0%
3.42
US$229,687
|
67,160
-19.0%
|
3.42
|
US$229,687
|
|
|
2026-05-18 |
2026-05-18 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
67,160
3.41
US$229,130
|
67,160
|
3.41
|
US$229,130
|
|
|
2026-05-18 |
2026-05-18 |
PrS
Proposed sale
|
Director
Non-Executive Director
|
67,160
3.41
US$229,130
|
67,160
|
3.41
|
US$229,130
|
|
|
2026-05-14 |
2026-05-14 |
PrS
Proposed sale
|
former CFO
|
886,341
3.45
US$3,057,876
|
886,341
|
3.45
|
US$3,057,876
|
|
|
2026-05-13 |
2026-05-13 |
S
Sale
|
CEO of Clover Care Services
Officer
|
98,039
-4.6%
3.52
US$345,097
|
98,039
-4.6%
|
3.52
|
US$345,097
|
|
|
2026-05-13 |
2026-05-13 |
PrS
Proposed sale
|
Officer
Officer
|
98,039
3.52
US$345,107
|
98,039
|
3.52
|
US$345,107
|
|
|
2026-03-18 |
2026-03-18 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
5,833
-0.2%
1.91
US$11,141
|
5,833
-0.2%
|
1.91
|
US$11,141
|
|
|
2026-03-18 |
2026-03-18 |
PrS
Proposed sale
|
Officer
Officer
|
5,833
1.93
US$11,258
|
5,833
|
1.93
|
US$11,258
|
|
|
2026-03-05 |
2026-03-04 |
S
Sale
|
CEO of Home Care
Officer
|
175,000
-8.1%
2.17
US$379,750
|
175,000
-8.1%
|
2.17
|
US$379,750
|
|
|
2026-03-04 |
2026-03-04 |
PrS
Proposed sale
|
Officer
Officer
|
175,000
2.17
US$378,945
|
175,000
|
2.17
|
US$378,945
|
|
|
2026-01-20 |
2026-01-20 |
PrS
Proposed sale
|
Officer
Officer
|
4,597
2.54
US$11,676
|
4,597
|
2.54
|
US$11,676
|
|
|
2026-01-20 |
2026-01-20 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
4,597
-0.2%
2.58
US$11,860
|
4,597
-0.2%
|
2.58
|
US$11,860
|
|
|
2026-01-07 |
2026-01-07 |
PrS
Proposed sale
|
Officer
Officer
|
2,102
2.59
US$5,444
|
2,102
|
2.59
|
US$5,444
|
|
|
2026-01-07 |
2026-01-07 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
2,102
-0.1%
2.53
US$5,318
|
2,102
-0.1%
|
2.53
|
US$5,318
|
|
|
2025-12-18 |
2025-12-18 |
PrS
Proposed sale
|
Officer
Officer
|
4,913
2.60
US$12,774
|
4,913
|
2.60
|
US$12,774
|
|
|
2025-12-18 |
2025-12-18 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
4,913
-0.2%
2.61
US$12,823
|
4,913
-0.2%
|
2.61
|
US$12,823
|
|
|
2025-11-05 |
2025-11-04 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
30,385
-1.1%
3.58
US$108,778
|
30,385
-1.1%
|
3.58
|
US$108,778
|
|
|
2025-11-04 |
2025-11-04 |
PrS
Proposed sale
|
Officer
Officer
|
30,385
3.68
US$111,817
|
30,385
|
3.68
|
US$111,817
|
|
|
2025-10-21 |
2025-10-17 |
PlS
Planned sale
|
CEO, Medicare Advantage
Officer
|
16,514
-0.6%
2.69
US$44,423
|
16,514
-0.6%
|
2.69
|
US$44,423
|
|